BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 9815234)

  • 1. Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection.
    DesJardin JA; Gibbons L; Cho E; Supran SE; Falagas ME; Werner BG; Snydman DR
    J Infect Dis; 1998 Dec; 178(6):1783-6. PubMed ID: 9815234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopic liver transplant recipients.
    DesJardin JA; Cho E; Supran S; Gibbons L; Werner BG; Snydman DR
    Clin Infect Dis; 2001 Oct; 33(8):1358-62. PubMed ID: 11565077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HHV-6 reactivation is often associated with CMV infection in liver transplant patients.
    Lautenschlager I; Linnavuori K; Lappalainen M; Suni J; Höckerstedt K
    Transpl Int; 2000; 13 Suppl 1():S351-3. PubMed ID: 11112030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human herpesvirus 6 in donor biopsies associated with the incidence of clinical cytomegalovirus disease and hepatitis C virus recurrence.
    Guardia AC; Stucchi RS; Sampaio AM; Milan A; Costa SC; Pavan CR; Boin Ide F
    Int J Infect Dis; 2012 Feb; 16(2):e124-9. PubMed ID: 22178541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-infection of two beta-herpesviruses (CMV and HHV-7) as an increased risk factor for 'CMV disease' in patients undergoing renal transplantation.
    Chapenko S; Folkmane I; Tomsone V; Amerika D; Rozentals R; Murovska M
    Clin Transplant; 2000 Oct; 14(5):486-92. PubMed ID: 11048994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary and recurrent cytomegalovirus infections have different effects on human herpesvirus-6 antibodies in immunosuppressed organ graft recipients: absence of virus cross-reactivity and evidence for virus interaction.
    Ward KN; Sheldon MJ; Gray JJ
    J Med Virol; 1991 Aug; 34(4):258-67. PubMed ID: 1658217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of human betaherpesviruses after renal transplantation: association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection.
    Kidd IM; Clark DA; Sabin CA; Andrew D; Hassan-Walker AF; Sweny P; Griffiths PD; Emery VC
    Transplantation; 2000 Jun; 69(11):2400-4. PubMed ID: 10868648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.
    Seishima M; Yamanaka S; Fujisawa T; Tohyama M; Hashimoto K
    Br J Dermatol; 2006 Aug; 155(2):344-9. PubMed ID: 16882173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus Hyper Immunoglobulin for CMV Prophylaxis in Thoracic Transplantation.
    Rea F; Potena L; Yonan N; Wagner F; Calabrese F
    Transplantation; 2016 Mar; 100 Suppl 3(Suppl 3):S19-26. PubMed ID: 26900991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human herpesvirus 6 and cytomegalovirus in ileocolonic mucosa in inflammatory bowel disease.
    Sipponen T; Turunen U; Lautenschlager I; Nieminen U; Arola J; Halme L
    Scand J Gastroenterol; 2011 Nov; 46(11):1324-33. PubMed ID: 21879802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients.
    Humar A; Malkan G; Moussa G; Greig P; Levy G; Mazzulli T
    J Infect Dis; 2000 Apr; 181(4):1450-3. PubMed ID: 10762575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG; Freeman R; Rohrer R
    Clin Transplant; 1997 Oct; 11(5 Pt 1):432-7. PubMed ID: 9361936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients.
    Snydman DR; Werner BG; Heinze-Lacey B; Berardi VP; Tilney NL; Kirkman RL; Milford EL; Cho SI; Bush HL; Levey AS
    N Engl J Med; 1987 Oct; 317(17):1049-54. PubMed ID: 2821397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the shedding of three β-herpesviruses DNA in Polish patients subjected to allogeneic hematopoietic stem cell transplantation: Six-year follow up.
    Dzieciatkowski T; Tomaszewska A; Przybylski M; Rusicka P; Basak GW; Jedrzejczak WW; Wroblewska M; Halaburda K
    J Clin Virol; 2016 Mar; 76():30-5. PubMed ID: 26809130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Cytomegalovirus disease" in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression?
    Osman HK; Peiris JS; Taylor CE; Warwicker P; Jarrett RF; Madeley CR
    J Med Virol; 1996 Apr; 48(4):295-301. PubMed ID: 8699160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of human herpesvirus 6 infection after liver transplantation.
    Humar A; Kumar D; Caliendo AM; Moussa G; Ashi-Sulaiman A; Levy G; Mazzulli T
    Transplantation; 2002 Feb; 73(4):599-604. PubMed ID: 11889438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and late virological monitoring of cytomegalovirus, Epstein-Barr virus, and human herpes virus 6 infections in small bowel/multivisceral transplant recipients.
    Petrisli E; Chiereghin A; Gabrielli L; Zanfi C; Lauro A; Piccirilli G; Baccolini F; Altimari A; Bagni A; Cescon M; Pinna AD; Landini MP; Lazzarotto T
    Transplant Proc; 2010; 42(1):74-8. PubMed ID: 20172284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-infection and clinical impact of human herpesvirus 5 and 6 in liver transplantation.
    Sampaio AM; Guardia AC; Milan A; Sasaki AN; Andrade PD; Bonon SH; Stucchi RS; Botelho Costa SC; Boin IF
    Transplant Proc; 2012 Oct; 44(8):2455-8. PubMed ID: 23026619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of HHV-6 antigens in biopsies of kidney transplant recipients with cytomegalovirus infection.
    Helanterä I; Loginov R; Koskinen P; Lautenschlager I
    Transpl Int; 2008 Oct; 21(10):980-4. PubMed ID: 18564986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.
    Bonaros N; Mayer B; Schachner T; Laufer G; Kocher A
    Clin Transplant; 2008; 22(1):89-97. PubMed ID: 18217909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.